Regencell Bioscience Holdings Ltd SEC EDGAR Filings (CIK 0001829667)

SEC EDGAR filings, ownership reports, and insider transactions for Regencell Bioscience Holdings Ltd.

Symbol
RGC on Nasdaq
Industry
Medicinal Chemicals & Botanical Products (Office Of Life Sciences)
Business address
11/F First Commercial Building, 33 35 Leighton Road, Causeway Bay, Hong Kong
State of incorporation
Cayman Islands
⭐ Add to watchlist ⭐
Regencell Bioscience Holdings Ltd has filed 64 SEC EDGAR filings since 13 Nov 2020

Latest Filings

Recent SEC filings for Regencell Bioscience Holdings Ltd including 20-F, SCHEDULE 13D/A, 6-K and more.

Form type Document Filing Description Filing date Reporting date File number(s)
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F ANNUAL REPORT 31 Oct 2025 30 Jun 2025 001-40617
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 11 Jul 2025 005-92718
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 30 Jun 2025 30 Jun 2025 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 30 Jun 2025 30 Jun 2025 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 17 Jun 2025 17 Jun 2025 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 02 Jun 2025 02 Jun 2025 001-40617
SCHEDULE 13D/A Open SCHEDULE 13D/A document | Open XBRL data View SEC filing for SCHEDULE 13D/A 13 Mar 2025 005-92718
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 15 Jan 2025 15 Jan 2025 001-40617
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F ANNUAL REPORT 25 Oct 2024 30 Jun 2024 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 20 Jun 2024 20 Jun 2024 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 02 Jan 2024 02 Jan 2024 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 15 Dec 2023 15 Dec 2023 001-40617
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F ANNUAL REPORT 27 Oct 2023 30 Jun 2023 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 15 Jun 2023 15 Jun 2023 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 05 Jun 2023 05 Jun 2023 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 17 Mar 2023 17 Mar 2023 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 28 Feb 2023 28 Feb 2023 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 04 Jan 2023 04 Jan 2023 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 22 Dec 2022 22 Dec 2022 001-40617
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F ANNUAL REPORT 31 Oct 2022 30 Jun 2022 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 12 Sep 2022 12 Sep 2022 001-40617
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 5 TO SCHEDULE 13D 26 Jul 2022 005-92718
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 02 Jun 2022 02 Jun 2022 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 18 May 2022 18 May 2022 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 16 May 2022 16 May 2022 001-40617
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 4 TO SCHEDULE 13D 16 May 2022 005-92718
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 26 Apr 2022 26 Apr 2022 001-40617
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D 04 Apr 2022 005-92718
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 16 Feb 2022 16 Feb 2022 001-40617
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 30 Dec 2021 005-92718
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 15 Dec 2021 005-92718
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 13 Dec 2021 13 Dec 2021 001-40617
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 22 Nov 2021 005-92718
6-K Open 6-K document View SEC filing for 6-K 17 Nov 2021 17 Nov 2021 001-40617
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F ANNUAL REPORT 29 Oct 2021 30 Jun 2021 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 07 Sep 2021 07 Sep 2021 001-40617
6-K Open 6-K document View SEC filing for 6-K CURRENT REPORT OF PRIVATE ISSUER 01 Sep 2021 01 Sep 2021 001-40617
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 20 Aug 2021 19 Aug 2021 001-40617
SC 13D Open SC 13D document View SEC filing for SC 13D SCHEDULE 13D 27 Jul 2021 005-92718
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 20 Jul 2021 20 Jul 2021 001-40617
424B4 Open 424B4 document View SEC filing for 424B4 PROSPECTUS 20 Jul 2021 333-254571
EFFECT Open EFFECT document View SEC filing for EFFECT 15 Jul 2021 333-254571
CERT Open CERT document View SEC filing for CERT 15 Jul 2021 001-40617
8-A12B Open 8-A12B document View SEC filing for 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 15 Jul 2021 001-40617
CORRESP Open CORRESP document View SEC filing for CORRESP 13 Jul 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 13 Jul 2021
FWP Open FWP document View SEC filing for FWP FREE WRITING PROSPECTUS 08 Jul 2021 333-254571
FWP Open FWP document View SEC filing for FWP FREE WRITING PROSPECTUS 30 Jun 2021 333-254571
F-1/A Open F-1/A document View SEC filing for F-1/A AMENDMENT NO. 3 TO FORM F-1 23 Jun 2021 333-254571
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Jun 2021
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 21 Jun 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 11 Jun 2021
F-1/A Open F-1/A document View SEC filing for F-1/A AMENDMENT NO. 2 TO FORM F-1 11 Jun 2021 333-254571
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 03 May 2021
F-1/A Open F-1/A document View SEC filing for F-1/A AMENDMENT NO. 1 TO FORM F-1 26 Apr 2021 333-254571
CORRESP Open CORRESP document View SEC filing for CORRESP 26 Apr 2021
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 05 Apr 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Mar 2021
F-1 Open F-1 document View SEC filing for F-1 REGISTRATION STATEMENT 22 Mar 2021 333-254571
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 18 Feb 2021
DRS/A Open DRS/A document View SEC filing for DRS/A 04 Feb 2021 377-03785
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 03 Feb 2021
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 11 Dec 2020
DRS Open DRS document View SEC filing for DRS 13 Nov 2020 377-03785

About this filer

Regencell Bioscience Holdings Ltd files with the SEC under CIK 0001829667. This page aggregates EDGAR filings and related ownership activity.

Industry: Medicinal Chemicals & Botanical Products.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages